SONAVEX, INC.

Profile

Company Names

SONAVEX, INC.

Addresses

2835 O-DONNELL STREET, SUITE 200, BALTIMORE, MD 21224

810 WYMAN PARK DRIVE, SUITE G02, BALTIMORE, MD 21211

810 WYMAN PARK DRIVE, SUITE G02, BALTIMORE, MD 21211

810 WYMAN PARK DRIVE, SUITE 120J, BALTIMORE, MD 21211

Phone Numbers

443.862.2024
443-797-2584

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$19,397,265.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2021-08-26 
$15,000,004.00 
$15,000,004.00 
$0.00 
Equity 
4
2019-10-11 
$1,800,000.00 
INDEFINITE 
INDEFINITE 
Equity 
3
2016-08-04 
$2,207,069.00 
$4,250,000.00 
$2,042,931.00 
Equity 
2
2015-10-14 
$320,192.00 
$320,192.00 
$0.00 
Equity 
1
2015-05-04 
$70,000.00 
$400,000.00 
$330,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
HALLENBECK 
DIRECTOR
MICHAEL 
J. 
HENNESSY, JR. 
DIRECTOR
DAVID 
 
NARROW 
EXECUTIVE OFFICER, DIRECTOR
BILL 
 
NILAND 
DIRECTOR
DEVIN 
 
O-BRIEN-COON 
EXECUTIVE OFFICER, DIRECTOR
JERRY 
 
PRINCE 
DIRECTOR
JERRY 
L. 
PRINCE 
DIRECTOR
JOHN 
 
RAPPE 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-11 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-05-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#